Chemistry:GW-1100
From HandWiki
GW-1100 (GW1100) is an experimental drug which acts as a potent and selective antagonist for the free fatty acid receptor FFAR1 (GPR40).[1][2] Agonists for this receptor have potentially useful antiinflammatory and anti-fibrotic effects, and while GW-1100 does not have therapeutic effects in its own right, it is important for research into the FFAR1 receptor as it allows comparison testing to measure the effectiveness of FFAR1 agonists.[1][3][4][5][6][7][8] GW-1100 also showed inhibition of cancer cell growth in vitro, suggesting potential applications of FFAR1 antagonists in the treatment of cancer.[9][10]
References
- ↑ 1.0 1.1 "Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: Identification of agonist and antagonist small molecules". British Journal of Pharmacology 148 (5): 619–628. 2006. doi:10.1038/sj.bjp.0706770. PMID 16702987.
- ↑ "[Possible involvement of FFAR1 signaling in mouse emotional behaviors through the regulation of brain monoamine releases]" (in Japanese). Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 158 (6): 454–459. 2023. doi:10.1254/fpj.23054. PMID 37914322.
- ↑ "Hypothalamic GPR40 Signaling Activated by Free Long Chain Fatty Acids Suppresses CFA-Induced Inflammatory Chronic Pain". PLOS ONE 8 (12). 2013. doi:10.1371/journal.pone.0081563. PMID 24349089. Bibcode: 2013PLoSO...881563N.
- ↑ "Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury". Experimental Neurology 290: 115–122. 2017. doi:10.1016/j.expneurol.2017.01.005. PMID 28077335.
- ↑ "Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice". PLOS ONE 12 (7). 2017. doi:10.1371/journal.pone.0180610. PMID 28723961. Bibcode: 2017PLoSO..1280610N.
- ↑ "The involvement of free fatty acid-GPR40/FFAR1 signaling in chronic social defeat stress-induced pain prolongation in C57BL/6J male mice". Psychopharmacology 235 (8): 2335–2347. 2018. doi:10.1007/s00213-018-4930-8. PMID 29931581.
- ↑ "GW9508 ameliorates cognitive impairment via the cAMP-CREB and JNK pathways in APPswe/PS1dE9 mouse model of Alzheimer's disease". Neuropharmacology 164. 2020. doi:10.1016/j.neuropharm.2019.107899. PMID 31809762.
- ↑ "Targeting FFA1 and FFA4 receptors in cancer-induced cachexia". American Journal of Physiology. Endocrinology and Metabolism 319 (5): E877–E892. 2020. doi:10.1152/ajpendo.00509.2019. PMID 32893672.
- ↑ "Induction of GPR40 positively regulates cell motile and growth activities in breast cancer MCF-7 cells". Journal of Receptor and Signal Transduction Research 38 (4): 311–315. 2018. doi:10.1080/10799893.2018.1494742. PMID 30111226.
- ↑ "Involvement of FFA1 and FFA4 in the regulation of cellular functions during tumor progression in colon cancer cells". Experimental Cell Research 369 (1): 54–60. 2018. doi:10.1016/j.yexcr.2018.05.005. PMID 29750897.
 |  |
